Relative effects of glucose-control strategy on microvascular disease.

Slides:

Advertisements

Similar presentations

ADVANCE - post trial ObservatioNal Study Key results “Hot Topics in Diabetes” 50 th EASD, Vienna 2014.

Advertisements

Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Influenza Vaccination and Cardiovascular.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Ethnic Differences in the Prognostic Value of Coronary.

Volume 376, Issue 9753, Pages (November 2010)

The SPRINT Research Group

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

Copyright © 2015 American Medical Association. All rights reserved.

Volume 14, Issue 10, Pages (September 2013)

Copyright © 2011 American Medical Association. All rights reserved.

Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis Zhaowei Zhu, Zhoujun Shen, Yingli Lu, Shan Zhong,

Copyright © 2012 American Medical Association. All rights reserved.

Perioperative Blood Transfusion Is Associated With Worse Clinical Outcomes in Resected Lung Cancer Ting Wang, MD, Lili Luo, MD, He Huang, MD, Jingrui.

Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies Mehran Rahimlu, MSc, Sakineh.

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

Paul D. Stein, MD, Russell D. Hull, MBBS, MSc, Fadi Matta, MD, Abdo Y

Volume 11, Issue 6, Pages (June 2010)

Volume 382, Issue 9891, Pages (August 2013)

George E. Kikano, MD, Marie T. Brown, MD Mayo Clinic Proceedings

CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies

A: Kaplan-Meier estimate of time to first LLA

Ashish Shukla et al. JACEP 2015;1:41-51

Perioperative Blood Transfusion Is Associated With Worse Clinical Outcomes in Resected Lung Cancer Ting Wang, MD, Lili Luo, MD, He Huang, MD, Jingrui.

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Prospective Studies Collaboration The.

Selected efficacy and safety parameters.

Yousef Rezaei, MD American Journal of Kidney Diseases

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

Volume 376, Issue 9753, Pages (November 2010)

Patient characteristics: American vs Canadian transplant patients

Cumulative incidences of events, according to glucose-control strategy

Volume 14, Issue 10, Pages (September 2013)

Characteristics of the Patients at Baseline*

Cause of death Treatment-arm events, % (n=45 054)

Relative Risk of Myopathy Associated with Selected Baseline Characteristics among 6031 Participants Assigned to 80 mg of Simvastatin Daily in SEARCH The.

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28.

Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: Duminda N Wijeysundera, MD, Jennifer S Naik, MD, W Scott Beattie, MD,

Relative Risk of Onset of Cancer from the Cholesterol Treatment Trialists’ (CTT) Meta-Analysis of Statin Trials, According to Year of Onset Risk ratios.

Volume 73, Issue 8, Pages (April 2008)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.

Risk of having any adverse effects with supplements compared with placebo. Risk of having any adverse effects with supplements compared with placebo. Stratified.

Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)

Flow chart of search strategy

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic.

Group differences (DKA vs

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Incidence of diabetes over time depends on GIS

A: Relative risk of experiencing one or more hypoglycemic events per participant at any time (24 h) and during the night (0000–0559 h) for Gla-300 vs.

Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),

HRs for prostate cancer by medication status.

Pooled risk with 95% CI of ACM (A) and CVD risk (B) for the highest vs

Scatterplot of the RR estimates of type 2 diabetes reported in the 15 included studies, and the pooled RR estimates with corresponding 95% CIs for five.

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Incidence of childhood type 1 diabetes in Western Australia from 1985 through Incidence of childhood type 1 diabetes in Western Australia from 1985.

The Kaplan-Meier curves display the time to event for the primary outcome (A) and total mortality (B) during follow-up from randomization until the end.

Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)

Effect of randomized treatment on all renal events (top) and the composite of all renal events, macrovascular events, or all-cause mortality (bottom) according.

Glycemic control and body weight over 52 weeks.

A: Forest plot of the HR of AE of bone fracture between the saxagliptin and placebo groups across subgroups by demographic and medical history parameters.

Median (interquartile range) of sensor glucose (A) and insulin delivery (B) during closed-loop (solid red line and red shaded area) and control period.

A: Probability of SICH by baseline glucose level.

Meta-analysis of five prospective studies examining the associations between urinary melatonin secretion and breast cancer risk. Meta-analysis of five.

Relative risks of colon cancer in prospective cohort studies, comparing the highest with the lowest category of heme iron consumption. Relative risks of.

Cryotherapy versus no cryotherapy for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic stem.

Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.

ROC curves showing the performance of the Diabetes Risk Score in predicting diabetes in the 1987 and 1992 cohorts; follow-up of both cohorts continued.

Cumulative mean numbers of confirmed (plasma glucose ≤3

Sensitivity and specificity of HbA1c, FPG, and 2hPG in identifying persons who developed diabetes within 10 years of screening among children and adolescents.

Presentation transcript:

Relative effects of glucose-control strategy on microvascular disease. Relative effects of glucose-control strategy on microvascular disease. The diamonds incorporate the point estimates, represented by the vertical dashed lines, and the 95% CIs of the overall effects within categories; for subcategories, black squares represent point estimates (with the area of the square proportional to the number of events), and horizontal lines represent 95% CIs. The hazard ratios and relative risk reductions are given for intensive glucose control compared with standard glucose control. Simon R. Heller, and on behalf of the ADVANCE Collaborative Group Dia Care 2009;32:S357-S361 ©2009 by American Diabetes Association